Stiripentol Uses, Dosage, Side Effects and Interactions
Diacomit
Diacomit was the first stiripentol product the FDA approved, in August 2018. No generic is listed as capsules and oral suspension.
Stiripentol (Diacomit) is an anti-seizure medicine used with clobazam to treat seizures caused by Dravet syndrome in infants and children.
Quick links
Ask Anything About StiripentolType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Stiripentol in Short
What it treatsStiripentol, sold as Diacomit, treats seizures linked to Dravet syndrome. It is for patients who are 6 months or older, weigh at least 7 kg, and already take clobazam. It has not been studied as a stand-alone treatment for Dravet syndrome. It is meant to be added to clobazam.
- How you get it Prescription only
- Comes asCapsule and oral suspensionAvailable strengths
Capsule (by mouth)
- 250 mg
- 500 mg
Oral suspension (by mouth)
- 250 mg
- 500 mg
- Crushing or chewingSome forms are on our Do Not Crush list Listed: Diacomit (capsule); Stiripentol (capsule)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs18 interact 1 major, 8 moderate and 9 minor
- What Medicaid pays
- Diacomit (brand)$35.76 to $72.20 a capsule
- Diacomit oral suspension: Medicaid paid $35.96 to $71.63 per mL
- Generic launchWhen will Diacomit go generic?
The Pharmacist’s Take
Stiripentol (Diacomit) is a specialist add-on medicine for seizures from Dravet syndrome, a rare, severe childhood epilepsy, and it is always used with clobazam. It may calm the brain through GABA-A receptors (the brain's calming signals) and slows the liver enzymes that clear clobazam, raising clobazam levels; it has been on the U.S. market since about 2018. Sleepiness is what families notice most, partly from those higher clobazam levels, along with poorer appetite and weight loss. Heavy or lasting drowsiness is the thing to watch and call about, since the clobazam dose may need lowering, and blood counts are checked before starting and every 6 months.
Key Takeaways From the HelloPharmacist Team
- Give it with meals, two or three times a day; swallow capsules whole, and give the powder right after mixing it in water.
- Never stop it suddenly, even if it disappoints; that can trigger more seizures or status epilepticus (a long, dangerous seizure).
- Check with the pharmacist before any new medicine, since stiripentol changes levels of many, and phenytoin, carbamazepine or phenobarbital can weaken it.
- Watch for new mood or behavior changes or talk of self-harm, and report them right away, as with any seizure medicine.
Patient Information Guide for Stiripentol
What It’s Used For
Stiripentol is used for one specific condition.
- Diacomit treats seizures associated with Dravet syndrome in patients taking clobazam who are 6 months or older and weigh 7 kg or more.
- There are no clinical data supporting Diacomit as the only medicine for Dravet syndrome.
How It Works
How stiripentol works against seizures in humans is unknown. It may act directly on GABA-A receptors, which help calm brain activity.
It may also block liver enzymes (cytochrome P450), which raises the blood levels of clobazam and its active metabolite.
Drug Class
WHO drug family
- Other antiepileptics
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)None. The FDA’s index lists no class of any kind for Stiripentol.
The main drug class the FDA gives it. It is the class named on the drug’s label.
What It Does in the Body
Physiologic effect (PE)None listed for Stiripentol in the FDA’s index.
From our Patient Information GuideHow stiripentol works against seizures in humans is unknown. It may act directly on GABA-A receptors, which help calm brain activity. Read How Stiripentol Works
A change it makes in how the body works.
Drug Family
WHO ATC classification- Other antiepileptics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.
Dosage
Diacomit is taken by mouth in 2 or 3 divided doses a day, based on age and weight. It is taken during a meal.
- Capsules: swallow whole with water. Don't open or break them.
- Powder for suspension: mix in water and drink right away.
- Missed dose: take it as soon as you can. If it's almost time for the next dose, skip it. Never double up.
- Stopping: your doctor will lower the dose gradually.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Seizures from Dravet syndrome (taken with clobazam)
Patients 1 year and older, 10 kg and above Usual dose 25 mg/kg twice a day or 16.67 mg/kg three times a day Highest dose 3000 mg a day
Step by step
- 25 mg/kg twice daily or 16.67 mg/kg three times daily, by mouth in equally divided doses
- Total daily dose 50 mg/kg/day
Children 6 months to less than 1 year old, 7 kg and above Usual dose 25 mg/kg twice a day Highest dose 3000 mg a day
Step by step
- 25 mg/kg twice daily, by mouth in equally divided doses
- Total daily dose 50 mg/kg/day
Good to know
Dosing frequency should not exceed twice daily to limit free water administration and to avoid overexposures
Children 1 year and older, 7 kg to less than 10 kg Usual dose 25 mg/kg twice a day Highest dose 3000 mg a day
Step by step
- 25 mg/kg twice daily, by mouth in equally divided doses
- Total daily dose 50 mg/kg/day
Good to know
Dosing frequency should not exceed twice daily to avoid overexposures
Side Effects
The most common side effects in studies were:
Common side effects
- Sleepiness (somnolence)
- Decreased appetite
- Weight loss
- Agitation
- Unsteady walking or balance (ataxia)
- Low muscle tone (hypotonia)
- Nausea
- Tremor, slurred speech or trouble sleeping
When to get medical help
- Call your doctor if sleepiness is heavy or lasts, especially alongside clobazam.
- Call your doctor if your child eats much less, loses weight, or is not growing as expected.
- Report new or worsening depression, unusual mood or behavior changes, or thoughts of self-harm right away.
- Seek help for signs that could point to low blood counts, as advised by your doctor. Blood tests are needed before starting and then every 6 months.
- Don't stop suddenly. Stopping too fast can increase seizures and cause status epilepticus (a prolonged, dangerous seizure).
Call your doctor about heavy sleepiness, major weight loss, mood changes, or thoughts of self-harm.
Warnings and Precautions
- Sleepiness: more likely with clobazam, alcohol or other sedating medicines. Avoid hazardous activities until you know how it affects you.
- Appetite and weight loss: growth in children should be monitored.
- Low neutrophils and platelets: blood counts are checked before starting and every 6 months.
- Stopping suddenly: can raise seizure frequency and cause status epilepticus.
- Suicidal thoughts: anti-seizure medicines can raise this risk, so watch for mood or behavior changes.
- PKU: the oral suspension contains phenylalanine.
Interactions
Stiripentol affects many liver enzymes, so it can change levels of other medicines.
- Clobazam: levels rise (about 2-fold for clobazam and 5-fold for its active metabolite), so clobazam may need to be lowered.
- Alcohol and other CNS depressants: more sleepiness.
- Rifampin, phenytoin, phenobarbital, carbamazepine: can lower stiripentol levels.
- Medicines such as theophylline, caffeine, sertraline, midazolam, triazolam, quinidine, diazepam, clopidogrel, methotrexate, prazosin and glyburide: doses may need adjusting.
Interactions Listed in the FDA-Approved Label
From the Stiripentol prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
What happensDIACOMIT inhibits CYP3A4 and CYP2C19 and increases plasma concentrations of clobazam and its active metabolite norclobazam, which may increase the risk of clobazam-related adverse reactions.What to doConsider a reduction in dosage of clobazam if adverse reactions are experienced.
-
CYP1A2 substrates For example: theophylline, caffeineWhat happensStiripentol is both an inhibitor and inducer of CYP1A2 in vitro, so drug-drug interactions are possible.What to doConsider dose adjustment of the substrate as clinically appropriate.
-
CYP2B6 substrates For example: sertraline, thiotepaWhat happensStiripentol is both an inhibitor and inducer of CYP2B6 in vitro, so drug-drug interactions are possible.What to doConsider dose adjustment of the substrate as clinically appropriate.
-
CYP3A4 substrates For example: midazolam, triazolam, quinidineWhat happensStiripentol is both an inhibitor and inducer of CYP3A4 in vitro, so drug-drug interactions are possible.What to doConsider dose adjustment of the substrate as clinically appropriate.
-
CYP2C8 and CYP2C19 substrates For example: diazepam, clopidogrelWhat happensPotential inhibition of enzyme activity by DIACOMIT.What to doConsider a reduction in dosage of the substrate if adverse reactions are experienced.
-
P-gp substrates For example: carbamazepineWhat happensPotential inhibition of transporter activity by DIACOMIT.What to doConsider a reduction in dosage of the substrate if adverse reactions are experienced.
-
BCRP substrates For example: methotrexate, prazosin, glyburideWhat happensPotential inhibition of transporter activity by DIACOMIT.What to doConsider a reduction in dosage of the substrate if adverse reactions are experienced.
-
Strong CYP1A2, CYP3A4 or CYP2C19 inducers For example: rifampin, phenytoin, phenobarbital, carbamazepineWhat happensInduction-based interactions may decrease DIACOMIT concentrations, as these enzymes all metabolize stiripentol.What to doConcomitant use should be avoided, or dosage adjustments should be made.
-
CNS depressants, including alcoholWhat happensConcomitant use may increase the risk of sedation and somnolence.
Read the label’s full interactions text
7 DRUG INTERACTIONS DIACOMIT increases the plasma concentration of clobazam and its metabolite through metabolic inhibition of CYP3A4 and CYP2C19. Consider dose reduction of clobazam in case of adverse reactions. Substrates of CYP2C8, CYP2C19, P-gp and BCRP may require a dose reduction. Substrates of CYP1A2, CYP2B6 and CYP3A4 may require a dose adjustment. Strong inducers of CYP1A2, CYP3A4 or CYP2C19: Consider dose increase of DIACOMIT. 7.1 Effect of DIACOMIT on Other Drugs CYP1A2, CYP2B6, CYP3A4, CYP2C8, CYP2C19, P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP) Substrates In vitro data show that stiripentol is both an inhibitor and inducer of CYP1A2, CYP2B6, and CYP3A4. Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT. Because of potential inhibition of enzyme/transporter activity, consider a reduction in dosage of substrates of CYP2C8, CYP2C19 (e.g., diazepam, clopidogrel), P-gp (e.g., carbamazepine), and BCRP (e.g., methotrexate, prazosin, glyburide), if adverse reactions are experienced when administered concomitantly with DIACOMIT. Clobazam Co-administration of DIACOMIT (which inhibits CYP 3A4 and 2C19) with clobazam results in increased plasma concentrations of clobazam (a substrate of CYP3A4) and norclobazam, the active metabolite of clobazam (a substrate of CYP2C19). This may increase the risk of clobazam-related adverse reactions. Consider a reduction in dosage of clobazam if adverse reactions are experienced when co-administered with DIACOMIT.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- No contraindications are listed.
- Not studied in babies under 6 months or under 7 kg.
- Not recommended with moderate or severe kidney or liver impairment.
- PKU: the oral suspension contains phenylalanine.
- Pregnancy: animal studies showed fetal harm. A pregnancy registry exists.
- Breastfeeding: no human data. Discuss with your doctor.
- Adults 65 and older: not studied.
Overdose
There are no human overdose data. In mice given very high doses, activity and breathing slowed. Treatment is supportive care. If you suspect an overdose, contact your regional Poison Control Center.
Half-Life and How Your Body Processes It
Stiripentol reaches peak blood levels in about 2 to 3 hours. It is 99% bound to proteins in the blood. It is mainly broken down by liver enzymes (CYP1A2, CYP2C19 and CYP3A4). Its half-life ranges from about 4.5 to 13 hours in adults, and it lengthens as body weight and dose increase. Exposure rises faster than the dose does.
Storage
Store in a dry place at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) . Store in original package to protect from light.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Stiripentol
From the licensed clinical database we use, rolled up per supplement, most serious first.18 supplements and herbal products have documented interactions with Stiripentol in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 1Major
- 8Moderate
- 9Minor
- ACTIVATED CHARCOALMajor
- CANNABIDIOL (CBD)Moderate
- COFFEE CHARCOALModerate
- EUROPEAN MANDRAKEModerate
- GLUCOMANNANModerate
- GUAR GUMModerate
- GUM ARABICModerate
- SLIPPERY ELMModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Stiripentol: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Stiripentol — the kind of thing our pharmacy team would talk through with you at the counter.
What is this medicine for?
How should we give it?
What side effects should we expect?
Are there any tests needed?
Can we stop it if it's not going well?
What about alcohol, other medicines or pregnancy?
Is stiripentol available over the counter?
When was stiripentol first available?
What is the brand name of stiripentol?
What is the generic name of Diacomit?
What strengths does stiripentol come in?
How much does stiripentol cost?
Is there a stiripentol shortage?
Where can I read the stiripentol prescribing information (package insert)?
Can you crush stiripentol?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Stiripentol
Skip the scrolling. Ask in your own words and get an answer from Stiripentol’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Stiripentol’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Stiripentol on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Stiripentol Forms and Strengths (How It Comes)
Stiripentol comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Stiripentol inactive ingredients by manufacturer.
Capsule
How this form is used
- Diacomit is used for seizures associated with Dravet syndrome in patients taking clobazam who are 6 months or older and weigh 7 kg or more.
- Diacomit capsules must be swallowed whole with a glass of water during a meal.
- Diacomit capsules should not be broken or opened.
- Diacomit capsules do not contain phenylalanine.
Oral suspension
How this form is used
- Diacomit is used for seizures associated with Dravet syndrome in patients taking clobazam who are 6 months or older and weigh 7 kg or more.
- Diacomit powder for oral suspension is mixed in a glass of water and taken right away during a meal.
- After drinking, add a small amount of water to the cup and drink it so no medicine is left behind.
- Diacomit for oral suspension contains phenylalanine, which matters for people with PKU.
Stiripentol on the U.S. Market: Products, Makers and Brands
How Stiripentol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 4 Stiripentol product records with the FDA, mostly as capsule, oral suspension; the earliest marketing or approval year on record is 2018. The one brand name in the directory today is Diacomit; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Stiripentol Is Used (Medicaid Data)
How many Stiripentol prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Stiripentol prescribed? Of the 1,682 medications we measure, Stiripentol ranks #1,159 by Medicaid prescriptions — more than 31% of them.
Utilization by Stiripentol product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
stiripentol 250 MG Oral Capsule Most dispensed
1 of 1 listed NDCs had Medicaid claims. RxNorm 2054973
stiripentol 250 MG Powder for Oral Suspension
1 of 1 listed NDCs had Medicaid claims. RxNorm 2055015
stiripentol 500 MG Oral Capsule
1 of 1 listed NDCs had Medicaid claims. RxNorm 2054981
stiripentol 500 MG Powder for Oral Suspension
1 of 1 listed NDCs had Medicaid claims. RxNorm 2055011
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 4 of the 4 listed Stiripentol NDCs had Medicaid claims.
Compare Stiripentol Products
A representative set of FDA-listed product records for Stiripentol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 250 mg | Oral | Biocodex, Inc. | NDA | View NDC → |
| 500 mg | Oral | Biocodex, Inc. | NDA | View NDC → |
| 💊Oral suspension | ||||
| 250 mg | Oral | Biocodex, Inc. | NDA | View NDC → |
| 500 mg | Oral | Biocodex, Inc. | NDA | View NDC → |
Showing 4 of 4 products — FDA National Drug Code Directory. See every product, package size and price: browse all 4 Stiripentol NDCs →
Stiripentol Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Stiripentol — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Stiripentol in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Stiripentol FDA Approval History
How Stiripentol went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Stiripentol Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Stiripentol recalls since July 2021.
✅No Stiripentol recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Stiripentol in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 2
- Strengths
- 4
- Forms in current FDA listings
- 2 of 2
RxCUI 2054968 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Stiripentol Supply and Shortage Status
Whether Stiripentol is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Medicaid Pays for Stiripentol
CMS’s weekly pharmacy survey (NADAC) has no price for Stiripentol, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.
| Form | Strength | Version | What Medicaid paid | |
|---|---|---|---|---|
| Capsule · Oral | 250 mg | Diacomit (brand) | $35.76 per capsule | NDC details & Medicaid use |
| Capsule · Oral | 500 mg | Diacomit (brand) | $72.20 per capsule | NDC details & Medicaid use |
| Oral suspension · Oral | 250 mg | Diacomit (brand) | $35.96 per mL | NDC details & Medicaid use |
| Oral suspension · Oral | 500 mg | Diacomit (brand) | $71.63 per mL | NDC details & Medicaid use |
Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.
Stiripentol Brand Names
Stiripentol has one brand name on record: Diacomit. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Stiripentol: Manufacturers and Labelers
One company lists Stiripentol products with the FDA. By number of product records, the largest are Biocodex, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Stiripentol Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Biocodex, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →